Vial
Vial
  • 101
  • 22 187
Webinar: Accelerating Ophthalmology Clinical Trials with Vial
Join Amy Del Medico, Vial’s Vice President of Ophthalmology, as she unveils how Vial’s cutting-edge technology transforms ophthalmology trials for biotech sponsors. Delve into Vial’s innovative CRO approach, uniquely designed to expedite and enhance clinical trial efficiency. Discover how Vial’s expertly assembled team merges clinical operations professionals with top-tier tech talent to develop pioneering technology platforms. Explore their streamlined startup app, proactive patient recruitment strategies, and advanced EDC system meticulously crafted for ophthalmology trials. Witness Vial’s unwavering commitment to fixed-price agreements, promising seamless collaboration for efficient and budget-conscious trials. Elevate your ophthalmology trials-watch now and partner with Vial for an unparalleled clinical trial experience.
Переглядів: 99

Відео

First in Human: The Panel Series, September 2023 hosted by Bruno Gagnon
Переглядів 334 місяці тому
Embark on an enlightening journey with “First in Human: The Panel Series,” where industry titans converge to delve into the core of operational brilliance. Led by host Bruno Gagnon, SVP of Global Clinical Operations at Opthea, this powerhouse panel features Natalie Masterton, VP of Clinical Development Operations at Chinook Therapeutics; Kristi Clark, VP of Clinical Operations at Avidity Biosci...
First in Human: The Panel Series, October 2023 hosted by Bruno Gagnon
Переглядів 264 місяці тому
Step into the world of ophthalmology clinical operations with “First in Human: The Panel Series,” now available on-demand featuring renowned biotech experts. In this insightful session, Bruno Gagnon, SVP of Global Clinical Operations at Opthea, led a dynamic panel including Jen Watts, VP of Clinical Operations, Early Development at Oculis; Dr. Rajat Agrawal, VP of Clinical Development and Ophth...
Podcast | First in Human Episode #62 featuring Josh Mandel-Brehm - CEO CAMP4 Therapeutics
Переглядів 264 місяці тому
Explore the untapped potential of RNA amplifying therapeutics with the CEO of CAMP4 Therapeutics, Josh Mandel-Brehm. We uncover the power of antisense oligonucleotides in rewriting the narrative for genetic diseases characterized by protein deficiency. Josh takes us behind the scenes of their innovative RNA Actuating Platform (RAP), a map charting the course of gene expression and a guide to th...
Podcast | First in Human Episode #61 featuring William Korinek - CEO and Co-Founder, Astrocyte
Переглядів 255 місяців тому
Embark on a journey through the neurons and synapses of brain science with William Korinek, the CEO of Astrocyte Pharmaceuticals. In a conversation that fuses the molecular intricacies of neuroprotection with the humanistic pursuit of medical advancement, Bill reveals his unique path from molecular biologist to biotech innovator. Together, we unravel the complexities of securing funding, the im...
Podcast | First in Human Episode #60 featuring Rachel Haines, VP of Clinical Operations, Rinri
Переглядів 2205 місяців тому
In this episode, Rachel Haines from Rinri Therapeutics joins us to discuss the possibilities of cell therapy for hearing loss. Our conversation with Rachel goes beyond just scientific innovation; we also explore the potential impact of Rinri's upcoming human trials, which are based on Professor Marcelo Rivolta's groundbreaking work. By delving into the challenges and excitement of pioneering cl...
Podcast | First in Human Episode #59 featuring Bas van der Baan - CEO of Lixte Biotechnology
Переглядів 225 місяців тому
Join as we dive deep into the world of oncology drug development with Bas van der Baan of Lixte. Discover the inspiration behind Lixte's focus on PP2A inhibitors and how this innovative approach is poised to revolutionize cancer treatment by enhancing chemotherapy and immunotherapy responses. Bas shares insights into ongoing clinical trials, regulatory considerations, and Lixte's ambitious long...
Podcast | First in Human Episode #58 featuring Samarendra Mohanty - President & CSO, Nanoscope
Переглядів 8576 місяців тому
Dr. Samar Mohanty, president and CSO of Nanoscope Therapeutics joins us to shed light on the revolutionary gene therapy that's giving hope to individuals with retinal degenerative diseases by pioneering a treatment that can re-sensitize the retina to detect low light levels. We open the curtains on their groundbreaking multi-characteristic opsins (MCOs), which have the potential to address all ...
Challenges in Oncology Clinical Trials, Tech Opportunities Driving Progress with Dr. Agarwal
Переглядів 566 місяців тому
Join Dr. Neeraj Agarwal to explore the intricacies of oncology trials and the potential of technology in overcoming these challenges. From patient enrollment hurdles to the future of personalized therapies and the role of AI, we navigate the landscape of oncology research to envision a brighter future for patients and clinicians alike. About Vial: Vial is a tech-enabled, next-generation CRO tha...
Vial Presents: Catching Up with Sarah Ruiz, Senior Director of Product Management Operations
Переглядів 736 місяців тому
We sit down with Sarah Ruiz who shares her journey to becoming a product management leader at Vial. Discover her winning strategies for boosting product efficiency and fostering top-tier teams. About Vial: Vial is a tech-enabled, next-generation CRO that promises faster and higher-quality execution of trials. The Vial Contract Research Organization (CRO) delivers on the promise of more efficien...
Challenges in Ophthalmology Trials, Innovations Shaping Ophthalmology's Future with Dr. Khanani
Переглядів 766 місяців тому
Join us as we discuss the future of retinal disease treatment with Dr. Arshad Khanani. Explore recent advancements in geographic atrophy, wet AMD, and diabetic retinopathy, emphasizing the significance of patient-centered trial design, the need for improved efficacy and the value of novel endpoints. To view the full episode transcript, click here: bit.ly/3TkMHL8 About Vial: Vial is a tech-enabl...
Podcast | First in Human Episode #57 featuring Rob Etherington - CEO & President at Clene
Переглядів 717 місяців тому
Imagine unlocking the secrets to revitalizing the brain's energy centers and turning the tide on neurodegenerative diseases. In this episode, Rob introduces us to CNM-Au8, an oral nanotherapeutic with the potential to recharge failing mitochondria. Our discussion traverses the innovative path Clene has charted, from the drug's conception to the exciting clinical trial results that highlight its...
Vial Presents: Challenges in Oncology Clinical Trials, Opportunities for Tech with Dr. Tolcher
Переглядів 697 місяців тому
From patient-reported outcomes to site selection strategies, Dr. Tolcher sheds light on the challenges and innovations shaping the next era of clinical trials. Discover how advancements in technology are revolutionizing the way we approach oncology research! To view the full episode transcript, click here: bit.ly/4c777QG About Vial: Vial is a tech-enabled, next-generation CRO that promises fast...
Podcast | First in Human Episode #56 featuring Jason Bock, Founder and CEO at CTMC
Переглядів 707 місяців тому
Step into the future as Dr. Jason Bock, founder and CEO of CTMC discusses the company's unique approach to accelerating cell therapies from development to testing, and the power of collaboration in reshaping the future of cancer treatment. Listen in as we discuss how CTMC's partnership with MD Anderson is not just technical but deeply human in nature, with the patient and personalized medicine ...
Podcast | First in Human Episode #55 featuring Alex Federation, Co-Founder at Talus Bio
Переглядів 457 місяців тому
Embark on a quest to unravel the 'undruggable' genome with Alex Federation, Co-founder of Talus Bio. Explore challenges in targeting transcription factors in cancer with Talus's innovative Marmot platform. Discover potential breakthroughs in rare diseases and pediatric cancers, and glimpse into the future of studying transcription factors within live human cells. Episodes launch weekly on Tuesd...
Vial Presents: Challenges in Oncology Clinical Trials, Opportunities for Tech with Dr. Brian Rini
Переглядів 1067 місяців тому
Vial Presents: Challenges in Oncology Clinical Trials, Opportunities for Tech with Dr. Brian Rini
Podcast | First in Human Episode #54 featuring Ahmed Hamdy, CEO at Vincerx Pharma
Переглядів 4327 місяців тому
Podcast | First in Human Episode #54 featuring Ahmed Hamdy, CEO at Vincerx Pharma
Podcast | First in Human Episode #53 featuring Sam Clark, CEO & Founder at Terran Biosciences
Переглядів 857 місяців тому
Podcast | First in Human Episode #53 featuring Sam Clark, CEO & Founder at Terran Biosciences
Vial Presents: Catching Up with Chris Tam, Software Engineering Lead
Переглядів 748 місяців тому
Vial Presents: Catching Up with Chris Tam, Software Engineering Lead
Podcast | First in Human Episode #52 featuring Mark McDonough, CEO at ChromaCode
Переглядів 248 місяців тому
Podcast | First in Human Episode #52 featuring Mark McDonough, CEO at ChromaCode
Podcast | First in Human Episode #51 featuring Bogdan Knezevic, Co-founder & CEO at Kaleidoscope.bio
Переглядів 498 місяців тому
Podcast | First in Human Episode #51 featuring Bogdan Knezevic, Co-founder & CEO at Kaleidoscope.bio
Podcast | First in Human Episode #50 featuring Steven Reed, CEO and co-founder of HDT-Bio
Переглядів 238 місяців тому
Podcast | First in Human Episode #50 featuring Steven Reed, CEO and co-founder of HDT-Bio
Vial Presents: Catching up with Brennan Lo, Product Designer
Переглядів 1009 місяців тому
Vial Presents: Catching up with Brennan Lo, Product Designer
Podcast | First in Human Episode #49 featuring Jeffrey Bacha, Chairman at Rakovina Therapeutics
Переглядів 499 місяців тому
Podcast | First in Human Episode #49 featuring Jeffrey Bacha, Chairman at Rakovina Therapeutics
Podcast | First in Human Episode #48 featuring Jonathan Thon, Founder & CEO at STRM.BIO
Переглядів 3910 місяців тому
Podcast | First in Human Episode #48 featuring Jonathan Thon, Founder & CEO at STRM.BIO
Vial Presents: Challenges in Running Clinical Trials, Protocol Design and Adaptation in CNS
Переглядів 7610 місяців тому
Vial Presents: Challenges in Running Clinical Trials, Protocol Design and Adaptation in CNS
Vial Presents: Catching Up with Connor McDiarmid, Battery Bio Strategy Manager
Переглядів 18510 місяців тому
Vial Presents: Catching Up with Connor McDiarmid, Battery Bio Strategy Manager
Podcast | First in Human Episode #47 featuring Oscar Segurado, CMO at ASC Therapeutics
Переглядів 3310 місяців тому
Podcast | First in Human Episode #47 featuring Oscar Segurado, CMO at ASC Therapeutics
Podcast | First in Human Episode #46 featuring Spiro Rombotis, CEO at Cyclacel
Переглядів 5810 місяців тому
Podcast | First in Human Episode #46 featuring Spiro Rombotis, CEO at Cyclacel
Vial Presents: Catching Up with Enejo Oruma, Clinical Data Manager
Переглядів 8211 місяців тому
Vial Presents: Catching Up with Enejo Oruma, Clinical Data Manager

КОМЕНТАРІ

  • @MucosalMelanomaSurvivor
    @MucosalMelanomaSurvivor 5 місяців тому

    I loved listening to this podcast. As I heavily pre-treated rare cancer patient, I had tried every existing traditional therapy and they all failed. I eventually got into a clinical trial for TIL therapy and it 100% eradicated my cancer and cured me. I was infused with my TIL on January 15 of 2020 followed up by 6 doses of IL-2. That was the last treatment I ever did and within less than 9 months I had a complete metabolic response. My entire life is now dedicated to sharing my story and educating the world about autologous CELL therapies. As current statistics say 1 of 2 people will develop some form of cancer in their lifetime, having curative treatments, especially customized one-time treatments, will help preserve quality of life and create more survivors for years to come. Patients want to win the war over just fighting the battle. In the coming years, we will look back at cancer and say “remember when we used to treat patients with cancer and now we CURE patients with cancer”.

    • @danielcatron1979
      @danielcatron1979 5 місяців тому

      Thanks for sharing your story. Wow, you must have been in one of the earlier clinical trials! Thanks for taking the risk and I'm pleased (but not surprised) that TIL has worked well for you. This treatment has such a long and powerful road ahead and this is a particularly exciting time for patients in need. Keep on sharing, as this helps so many who have no clue what to do after a cancer diagnosis-I have been there too. It's so critically important to keep hope alive by focusing on next steps and not on giving up or hopelessness.

  • @zagreb2012
    @zagreb2012 6 місяців тому

    Great stuff

  • @jaimehansen5024
    @jaimehansen5024 7 місяців тому

    promo sm

  • @LayneSadler
    @LayneSadler 11 місяців тому

    ML is just an association study that allows features to interact with each other to give you a sample-specific probability for an outcome. It tells you if you data allows your to answer your question. So don't hate on ML... hate on the data you're gathering

  • @alinedasilveirabrasil
    @alinedasilveirabrasil Рік тому

    Interesting learning video

  • @nhungluong5133
    @nhungluong5133 Рік тому

    Very charismatic.

  • @Fishingbyfaruk
    @Fishingbyfaruk Рік тому

    HI! dear I'm Freelancer Faruk. Professional UA-cam Channel & SEO Expert. Dear Sir, Let me know if you need any help. thank you

  • @Fishingbyfaruk
    @Fishingbyfaruk Рік тому

    Hello, I hope you are doing well. I am a professional digital marketer and UA-cam channel promotion expert for monetization. I completed my lengthy training in an outsourcing lab in Bangladesh. You can get a corporate video or UA-cam channel that can reach millions of people around the world. Note: I am a freelancer. Dear sir let me know if you need help.

  • @rhett2036
    @rhett2036 2 роки тому

    😪 𝓟Ř𝔬𝓂𝔬𝐒ϻ

  • @SimonBurns77
    @SimonBurns77 2 роки тому

    Great interview Betsey and Dr. Siegfried!